ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $12,900 | +3.2% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q4 2023 | $12,500 | +23.2% | 5,000 | 0.0% | 0.00% | – |
| Q3 2023 | $10,150 | -11.7% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $11,500 | -24.1% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $15,150 | +126150.0% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $12 | -99.9% | 5,000 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | -28.6% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $14,000 | -6.7% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $15,000 | -21.1% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $19,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,651,825 | $19,358,000 | 6.60% |
| RTW INVESTMENTS, LP | 5,165,499 | $37,708,000 | 2.72% |
| Eversept Partners, LP | 97,495 | $711,714 | 0.33% |
| Seelaus Asset Management LLC | 14,300 | $104,000 | 0.09% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,315 | $8,827,000 | 0.08% |
| ALGERT GLOBAL LLC | 34,816 | $254,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 48,000 | $350,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 211,115 | $1,540,000 | 0.03% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,000,400 | $29,203,000 | 0.02% |
| PDT Partners, LLC | 66,965 | $489,000 | 0.02% |